Research Article

Traditional Chinese Medicine Compound Preparations Are Associated with Low Disease-Related Complication Rates in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study of 11,074 Patients

Table 3

Association between traditional Chinese medicine compound preparation with rheumatoid arthritis-related inflammatory and immune indices.

TCMCPIndexes valueOR95% CI

XFCCRP ↓4.2640.0391.2161.010-1.463
XFCESR ↓9.0260.0031.2981.095-1.539
XFCC4 ↓4.8200.0281.2581.025-1.544
HQCCRP ↓24.65<0.0011.6411.348-1.998
HQCESR ↓10.0010.0021.3241.112-1.575
HQCC4 ↓5.0950.0241.2721.032-1.569
HQCIgG ↓5.5090.0191.2471.037-1.499
HQCIgA ↓5.2850.0221.2371.032-1.484

Note: TCMCP: users of traditional Chinese medicine compound preparation; XFC: Xinfeng capsule; HQC: Huangqin Qingre capsule; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; C4: complement C4; IgG: immunoglobulin G; IgA: immunoglobulin A. “↓” represents the decrease of quantitative variables, indicating that the laboratory indicators improved after TCMCP treatment.